Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-13

FDA Approved: FLUVOXAMINE MALEATE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA granted approval of a supplemental application for fluvoxamine maleate from Chartwell RX, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluvoxamine (fluvoxamine)

Snippet

SUPPL AP for FLUVOXAMINE MALEATE (FLUVOXAMINE MALEATE)